Pharmacogenomics in Stroke: Feasibility of CYP2C19 Testing
Pharmacogenomics in Stroke: Feasibility of CYP2C19 Testing
Recruiting · NCT06943586 · Registry updated 2026-04-23Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Pharmacogenomics in Stroke: Feasibility of CYP2C19 Testing | brain disorder, brain ischemia, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, nervous system disorder, stroke disorder, transient ischemic attack, vascular disorder | Recruiting | Not applicable | 2026-04-23 | NCT06943586 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| University of Alabama at Birmingham | 467 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| University of Alabama at Birmingham | Birmingham | United States | 193 |